Samir Merheb1, Na Wang2, Janice Weinberg3, David S Wang1, Shaun E L Wason4. 1. Boston University / Boston Medical Center, 725 Albany St., Suite 3B, Boston, MA, 02118, USA. 2. Biostatistics and Epidemiology Data Analytics Center at Boston University, School of Public Health, Boston University, 85 East Newton St, Boston, MA, M92102118, USA. 3. School of Public Health, Department of Biostatistics, Boston University, 801 Massachusetts Avenue 3rd Floor, Boston, MA, 02118, USA. 4. Boston University / Boston Medical Center, 725 Albany St., Suite 3B, Boston, MA, 02118, USA. swason@bu.edu.
Abstract
PURPOSE: Online health information-seeking behavior has increased over the past 15 years; however, little is known about the online interest for surgical treatment of men with benign prostatic hyperplasia. We used Google Trends to evaluate online interest for various surgical procedures for benign prostatic hyperplasia in the US and worldwide. METHODS: Transurethral resection of the prostate, photoselective vaporization of the prostate, Holmium laser enucleation of the prostate, Urolift, and Rezum were selected as search terms of interest within Google Trends. Google Trends normalizes the popularity of search terms on a 0-100 scale. ANOVA and the average rate of change in popularity scores were conducted from July 2015 to February 2019. RESULTS: From 2004 to 2019, online interest in transurethral resection of the prostate and photoselective vaporization of the prostate remained stable in the US and worldwide; meanwhile, there was an upward trend for Urolift and Rezum. There was a statistically significant increase in the online interest for Holmium laser enucleation of the prostate in the US and worldwide; however, the mean popularity score was significantly higher worldwide. CONCLUSIONS: A shift in online interest towards minimally invasive surgical therapies for benign prostatic hyperplasia was demonstrated in the US and worldwide and parallels clinical practice patterns, such as HoLEP and Urolift surgical volumes in Indiana and Australia, respectively. Google Trends can be used in real-time to gauge online interest for surgical procedures and help guide physician-patient counseling.
PURPOSE: Online health information-seeking behavior has increased over the past 15 years; however, little is known about the online interest for surgical treatment of men with benign prostatic hyperplasia. We used Google Trends to evaluate online interest for various surgical procedures for benign prostatic hyperplasia in the US and worldwide. METHODS: Transurethral resection of the prostate, photoselective vaporization of the prostate, Holmium laser enucleation of the prostate, Urolift, and Rezum were selected as search terms of interest within Google Trends. Google Trends normalizes the popularity of search terms on a 0-100 scale. ANOVA and the average rate of change in popularity scores were conducted from July 2015 to February 2019. RESULTS: From 2004 to 2019, online interest in transurethral resection of the prostate and photoselective vaporization of the prostate remained stable in the US and worldwide; meanwhile, there was an upward trend for Urolift and Rezum. There was a statistically significant increase in the online interest for Holmium laser enucleation of the prostate in the US and worldwide; however, the mean popularity score was significantly higher worldwide. CONCLUSIONS: A shift in online interest towards minimally invasive surgical therapies for benign prostatic hyperplasia was demonstrated in the US and worldwide and parallels clinical practice patterns, such as HoLEP and Urolift surgical volumes in Indiana and Australia, respectively. Google Trends can be used in real-time to gauge online interest for surgical procedures and help guide physician-patient counseling.
Authors: Kevin T McVary; Steven N Gange; Neal D Shore; Damien M Bolton; Barrett E Cowan; B Thomas Brown; Alexis E Te; Peter T Chin; Daniel B Rukstalis; Claus G Roehrborn Journal: J Sex Med Date: 2013-09-30 Impact factor: 3.802
Authors: Christian Gratzke; Neil Barber; Mark J Speakman; Richard Berges; Ulrich Wetterauer; Damien Greene; Karl-Dietrich Sievert; Christopher R Chapple; Jacob M Patterson; Lasse Fahrenkrug; Martin Schoenthaler; Jens Sonksen Journal: BJU Int Date: 2016-12-21 Impact factor: 5.588
Authors: Claus G Roehrborn; Steven N Gange; Marc C Gittelman; Kenneth A Goldberg; Kalpesh Patel; Neal D Shore; Richard M Levin; Michael Rousseau; J Randolf Beahrs; Jed Kaminetsky; Barrett E Cowan; Christopher H Cantrill; Lance A Mynderse; James C Ulchaker; Thayne R Larson; Christopher M Dixon; Kevin T McVary Journal: J Urol Date: 2016-12-18 Impact factor: 7.450
Authors: James A Thomas; Andrea Tubaro; Neil Barber; Frank d'Ancona; Gordon Muir; Ulrich Witzsch; Marc-Oliver Grimm; Joan Benejam; Jens-Uwe Stolzenburg; Antony Riddick; Sascha Pahernik; Herman Roelink; Filip Ameye; Christian Saussine; Franck Bruyère; Wolfgang Loidl; Tim Larner; Nirjan-Kumar Gogoi; Richard Hindley; Rolf Muschter; Andrew Thorpe; Nitin Shrotri; Stuart Graham; Moritz Hamann; Kurt Miller; Martin Schostak; Carlos Capitán; Helmut Knispel; Alexander Bachmann Journal: Eur Urol Date: 2015-08-15 Impact factor: 20.096
Authors: Harris E Foster; Michael J Barry; Philipp Dahm; Manhar C Gandhi; Steven A Kaplan; Tobias S Kohler; Lori B Lerner; Deborah J Lightner; J Kellogg Parsons; Claus G Roehrborn; Charles Welliver; Timothy J Wilt; Kevin T McVary Journal: J Urol Date: 2018-06-11 Impact factor: 7.450
Authors: Giovanni E Cacciamani; Silvia Bassi; Marco Sebben; Anna Marcer; Giorgio I Russo; Andrea Cocci; Paolo Dell'Oglio; Luis G Medina; Nima Nassiri; Alessandro Tafuri; Andre Abreu; Antonio B Porcaro; Alberto Briganti; Francesco Montorsi; Inderbir S Gill; Walter Artibani Journal: Eur Urol Oncol Date: 2019-07-31